48,817 DEAD and 5,107,883 Injured Following COVID-19 Vaccines in European Database of Adverse Reactions

The European (EEA and non-EEA countries) database of suspected drug reaction reports is EudraVigilance, verified by the European Medicines Agency (EMA), and they are now reporting 48,817 fatalities, and 5,107,883 injuries following injections of four experimental COVID-19 shots:

COVID-19 MRNA VACCINE MODERNA (CX-024414)
COVID-19 MRNA VACCINE PFIZER-BIONTECH
COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
COVID-19 VACCINE JANSSEN (AD26.COV2.S)
From the total of injuries recorded, almost half of them (2,177,286) are serious injuries.

“Seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical occurrence that results in death, is life-threatening, requires inpatient hospitalisation, results in another medically important condition, or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, or is a congenital anomaly/birth defect.”

A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. It is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.

Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.*

Here is the summary data through November 12, 2022.

Total reactions for the mRNA vaccine Tozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer – 23,210 deaths and 2,667,243 injuries to 12/11/2022:
79,297 Blood and lymphatic system disorders incl. 335 deaths
90,887 Cardiac disorders incl. 3,351 deaths
842 Congenital, familial and genetic disorders incl. 66 deaths
33,754 Ear and labyrinth disorders incl. 22 deaths
3,497 Endocrine disorders incl. 13 deaths
38,206 Eye disorders incl. 64 deaths
184,670 Gastrointestinal disorders incl. 915 deaths
688,114 General disorders and administration site conditions incl. 6,286 deaths
3,020 Hepatobiliary disorders incl. 133 deaths
28,472 Immune system disorders incl. 156 deaths
183,898 Infections and infestations incl. 2,392 deaths
46,012 Injury, poisoning and procedural complications incl. 551 deaths
63,046 Investigations incl. 630 deaths
16,685 Metabolism and nutrition disorders incl. 406 deaths
298,841 Musculoskeletal and connective tissue disorders incl. 331 deaths
3,302 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 301 deaths
407,210 Nervous system disorders incl. 2,482 deaths
3,515 Pregnancy, puerperium and perinatal conditions incl. 83 deaths
342 Product issues incl. 4 deaths
46,792 Psychiatric disorders incl. 267 deaths
9,544 Renal and urinary disorders incl. 352 deaths
117,187 Reproductive system and breast disorders incl. 11 deaths
107,494 Respiratory, thoracic and mediastinal disorders incl. 2,481 deaths
117,035 Skin and subcutaneous tissue disorders incl. 207 deaths
7,110 Social circumstances incl. 30 deaths
29,524 Surgical and medical procedures incl. 309 deaths
58,947 Vascular disorders incl. 1,032 deaths
Total reactions for the mRNA vaccine SPIKEVAX/mRNA-1273(CX-024414) from Moderna – 12,703 deaths and 870,106 injuries to 12/11/2022:

23,093 Blood and lymphatic system disorders incl. 152 deaths
30,044 Cardiac disorders incl. 1,415 deaths
269 Congenital, familial and genetic disorders incl. 16 deaths
10,043 Ear and labyrinth disorders incl. 8 deaths
951 Endocrine disorders incl. 6 deaths
11,407 Eye disorders incl. 42 deaths
67,342 Gastrointestinal disorders incl. 487 deaths
229,166 General disorders and administration site conditions incl. 4,057 deaths
1,148 Hepatobiliary disorders incl. 69 deaths
9,547 Immune system disorders incl. 46 deaths
38,244 Infections and infestations incl. 1,153 deaths
12,405 Injury, poisoning and procedural complications incl. 250 deaths
19,071 Investigations incl. 413 deaths
6,813 Metabolism and nutrition disorders incl. 300 deaths
107,976 Musculoskeletal and connective tissue disorders incl. 251 deaths
1,156 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 115 deaths
142,329 Nervous system disorders incl. 1,231 deaths
1,154 Pregnancy, puerperium and perinatal conditions incl. 13 deaths
149 Product issues incl. 3 deaths
14,434 Psychiatric disorders incl. 201 deaths
4,428 Renal and urinary disorders incl. 244 deaths
25,857 Reproductive system and breast disorders incl. 11 deaths
34,767 Respiratory, thoracic and mediastinal disorders incl. 1,337 deaths
45,736 Skin and subcutaneous tissue disorders incl. 118 deaths
3,412 Social circumstances incl. 46 deaths
11,812 Surgical and medical procedures incl. 228 deaths
17,353 Vascular disorders incl. 491 deaths
Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ Astra Zeneca – 9,667deaths and 1,388,494 injuries to 12/11/2022:

15,933 Blood and lymphatic system disorders incl. 360 deaths
24,615 Cardiac disorders incl. 1,012 deaths
298 Congenital familial and genetic disorders incl. 12 deaths
15,431 Ear and labyrinth disorders incl. 8 deaths
876 Endocrine disorders incl. 8 deaths
22,942 Eye disorders incl. 34 deaths
123,551 Gastrointestinal disorders incl. 511 deaths
376,016 General disorders and administration site conditions incl. 2,239 deaths
1,253 Hepatobiliary disorders incl. 91 deaths
7,141 Immune system disorders incl. 49 deaths
59,884 Infections and infestations incl. 818 deaths
15,929 Injury poisoning and procedural complications incl. 239 deaths
33,678 Investigations incl. 228 deaths
15,264 Metabolism and nutrition disorders incl. 150 deaths
201,842 Musculoskeletal and connective tissue disorders incl. 199 deaths
969 Neoplasms benign malignant and unspecified (incl cysts and polyps) incl. 65 deaths
276,325 Nervous system disorders incl. 1,402 deaths
740 Pregnancy puerperium and perinatal conditions incl. 23 deaths
216 Product issues incl. 1 death
24,640 Psychiatric disorders incl. 88 deaths
5,020 Renal and urinary disorders incl. 107 deaths
18,719 Reproductive system and breast disorders incl. 3 deaths
48,116 Respiratory thoracic and mediastinal disorders incl. 1,271 deaths
60,805 Skin and subcutaneous tissue disorders incl. 81 deaths
2,537 Social circumstances incl. 11 deaths
3,529 Surgical and medical procedures incl. 45 deaths
32,225 Vascular disorders incl. 612 deaths
Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson – 3,234 deaths and 178,053 injuries to 12/11/2022:

1,794 Blood and lymphatic system disorders incl. 72 deaths
3,948 Cardiac disorders incl. 267 deaths
64 Congenital, familial and genetic disorders incl. 3 deaths
1,946 Ear and labyrinth disorders incl. 3 deaths
164 Endocrine disorders incl. 2 deaths
2,337 Eye disorders incl. 16 deaths
11,933 Gastrointestinal disorders incl. 129 deaths
49,033 General disorders and administration site conditions incl. 897 deaths
221 Hepatobiliary disorders incl. 23 deaths
848 Immune system disorders incl. 12 deaths
16,007 Infections and infestations incl. 273 deaths
1,699 Injury, poisoning and procedural complications incl. 38 deaths
8,184 Investigations incl. 171 deaths
1,142 Metabolism and nutrition disorders incl. 88 deaths
22,051 Musculoskeletal and connective tissue disorders incl. 74 deaths
160 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 14 deaths
30,257 Nervous system disorders incl. 317 deaths
135 Pregnancy, puerperium and perinatal conditions incl. 1 death
38 Product issues
2,651 Psychiatric disorders incl. 37 deaths
773 Renal and urinary disorders incl. 53 deaths
4,159 Reproductive system and breast disorders incl. 7 deaths
6,227 Respiratory, thoracic and mediastinal disorders incl. 405 deaths
5,438 Skin and subcutaneous tissue disorders incl. 17 deaths
718 Social circumstances incl. 8 deaths
1,332 Surgical and medical procedures incl. 104 deaths
4,794 Vascular disorders incl. 203 deaths
Total reactions for the COVID-19 vaccine NUVAXOVID(NVX-COV2373) from Novavax – 3 deaths and 3,987 injuries to 12/11/2022:
90 Blood and lymphatic system disorders
243 Cardiac disorders
0 Congenital familial and genetic disorders
56 Ear and labyrinth disorders
1 Endocrine disorders
82 Eye disorders
262 Gastrointestinal disorders
861 General disorders and administration site conditions incl. 1 death
5 Hepatobiliary disorders
41 Immune system disorders
205 Infections and infestations
43 Injury poisoning and procedural complications
107 Investigations
22 Metabolism and nutrition disorders
497 Musculoskeletal and connective tissue disorders
2 Neoplasms benign malignant and unspecified (incl cysts and polyps)
705 Nervous system disorders
2 Pregnancy puerperium and perinatal conditions
3 Product issues
67 Psychiatric disorders
21 Renal and urinary disorders
78 Reproductive system and breast disorders
204 Respiratory thoracic and mediastinal disorders incl. 1 death
255 Skin and subcutaneous tissue disorders
7 Social circumstances
34 Surgical and medical procedures
94 Vascular disorders incl. 1 death

*These totals are estimates based on reports submitted to EudraVigilance. Totals may be much higher based on percentage of adverse reactions that are reported. Some of these reports may also be reported to the individual country’s adverse reaction databases, such as the U.S. VAERS database and the UK Yellow Card system. The fatalities are grouped by symptoms, and some fatalities may have resulted from multiple symptoms.

Sudden Deaths and Injuries Among Young and Formerly Healthy People Continue

24-Year-Old British Professional Athlete and Actress Genevieve Florence. (Left 2 image sources.)

Sudden deaths and injuries continue to be reported all across Europe and around the world, and more and more European politicians are beginning to speak out about how deadly the COVID-19 vaccines are.

But instead of halting these vaccines, the EMA has actually just approved a new COVID-19 vaccine by GSK and Sanofi.

After months of review at European regulators’ desks, GSK and Sanofi have scored a world-first nod to enter the COVID-19 vaccine market in Europe with their pandemic booster VidPrevtyn Beta.

Thursday, the European Commission signed off on the Sanofi-GSK booster to augment protection against COVID-19 in adults ages 18 and up, making VidPrevtyn the first next-gen, protein-based adjuvanted COVID-19 vaccine approved in Europe. (Full article.)

Australia has done the exact opposite, and has stated they are NOT approving new COVID-19 boosters for those under the age of 30 due to the high risks of heart disease from the shots.

The Australian government says the risk of myocarditis from a COVID booster might be greater than COVID itself — so it won’t allow people under 30 to get a fourth vaccine.

“In males aged 16-40 years, it is uncertain whether the risk following COVID-19 remains higher than the risk following vaccination,” the government said. (Full article.)

Here is the latest montage of young victims who have either suffered “sudden deaths” or crippling injuries. It starts with the testimony of 24-year-old British professional athlete and actress Genevieve Florence, who was mandated to get the shots to be able to continue filming, and totally disabled her.

Source: https://vaccineimpact.com/2022/48817-dead-and-5107883-injured-following-covid-19-vaccines-in-european-database-of-adverse-reactions/